Today my guest is <a href='https://www.newcastle-hospitals.nhs.uk/consultants/mr-james-talks/'>Mr James Talks</a>, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organisation can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimise adherence to treatment. Speaker disclosures: Professor Anat Loewenstein Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane Mr James Talks Consultancy, Research grants: Allergan, Bayer,  Boehringer Ingelheim, Novartis, Roche

Ways to engage with patients to enable realistic expectation-setting

"A Chat with Anat" is a series for ophthalmologists who are interested in improving delivery of care for patients living with retinal disease, and for those interested in clinically-challenging situations or controversies in care. I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss these important topics. This podcast series is sponsored and organized by Bayer and produced by ApotheCom.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. This is not intended for UK audiences.&nbsp;